Digimed Updates
  • Home
  • SAHI Updates
  • News
  • Conference
    • ADA 2025
    • HFAI 2025
    • ATTD 2024
    • ADA 2024
    • ENDO 2022
    • ESH 2022
    • ADA 2022
    • AACE 2022
    • EASD-2021
    • HFSA-2021
    • ESC-2021
    • ADA 2021
    • ACC-2021
    • ESH-ISH-2021
    • ADA 2020
    • RSSDI 2020
    • ACC-2020
    • IDF-2019
    • EASD-2019
    • ESH-2019
    • ADA-2019
    • RSSDI-2018
    • EASD-2018
  • Specialties
    • Cardiology
    • Endocrinology
    • Conference Update
    • Other Specialties Conference
  • Subscribe
  • Contact
Select Page
FURIN Expression in Vascular Endothelial Cells Is Modulated by a Coronary Artery Disease Associated Genetic Variant and Influences Monocyte Transendothelial Migration

FURIN Expression in Vascular Endothelial Cells Is Modulated by a Coronary Artery Disease Associated Genetic Variant and Influences Monocyte Transendothelial Migration

A coronary artery disease (CAD) responsiveness is focused on chromosome 15q26.1, recognized by genome-wide association studies.

29 European Meeting on Hypertension and Cardiovascular Protection, Milan, Italy, June 21st-24th 2019 (ESH 2019)

29 European Meeting on Hypertension and Cardiovascular Protection, Milan, Italy, June 21st-24th 2019 (ESH 2019)

ESH Congress was held from June 21-24th, 2019 in Milan, Italy. The ESH is a stable and organised European platform for scientific exchange in hypertension. Carbon Brand Solutions was indeed fortunate to attend and cover the exciting live sessions and interview some of the KOL’s who threw significant light on the different aspects of hypertension.

Advanced Heart Failure in Adults with Congenital Heart Disease

Advanced Heart Failure in Adults with Congenital Heart Disease

>90% of children born with CHD are expected to survive to adulthood because of enhancements in care for patients with congenital heart disease (CHD).

5 Common Drugs You Should Consider Deprescribing

5 Common Drugs You Should Consider Deprescribing

Nearly 50% of older adults take five or more medications, and at least one in five of these prescriptions is potentially inadequate.

Declining Clinical Benefit of ICD in Heart Failure Patients: Temporal Trend of Mortality Outcomes from Randomized Controlled Trials

Declining Clinical Benefit of ICD in Heart Failure Patients: Temporal Trend of Mortality Outcomes from Randomized Controlled Trials

The risk of sudden cardiac death in patients with heart failure has declined over time thanks to the sequential introduction of new treatments.

« Older Entries
Next Entries »
« Previous 1 … 68 69 70 71 72 … 74 Next »
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
© 2021 Digimed India. All rights reserved.
  • Home
  • News
  • Conference
  • Subscribe
  • Contact
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress